GlassScriptPhysician profile
Michelle Pinto
NPI 1427888742
$1,084.25
in general payments reported to CMS, 2019-2025
19 companies · $820 in 2025
The $820 reported for 2025 was more than what 82% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $264 · 2025: $820.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,084.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,084.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $209.98 | 2024-2025 | Rexulti |
| Exact Sciences Corporation | $149.01 | 2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Neurocrine Biosciences, INC. | $148.68 | 2025 | |
| Eisai INC. | $79.60 | 2024-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $66.86 | 2024-2025 | Xifaxan |
| Daiichi Sankyo INC. | $56.86 | 2024-2025 | Injectafer |
| Lundbeck LLC | $56.67 | 2024-2025 | Rexulti |
| Astellas Pharma US INC | $41.61 | 2024 | Veozah |
| Abbvie INC. | $37.18 | 2025 | |
| Renalytix Ai, INC. | $37.00 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Corcept Therapeutics | $34.20 | 2024-2025 | Korlym |
| Novo Nordisk INC | $30.85 | 2025 | Ozempic |
| Bayer Healthcare Pharmaceuticals INC. | $26.72 | 2024 | |
| Janssen Pharmaceuticals, INC | $24.02 | 2024 | Spravato |
| Smith+Nephew, INC. | $21.46 | 2025 | Collagenase Santyl |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $18.43 | 2025 | Nuplazid |
| Insmed, INC. | $15.41 | 2025 | Brinsupri, Arikayce |
| Lilly USA, LLC | $15.29 | 2025 | Mounjaro |
| Amgen INC. | $14.42 | 2025 | Repatha, Otezla |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Pinto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.